UK markets closed

IGC Pharma, Inc. (IGC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.4000-0.0065 (-1.60%)
At close: 04:00PM EDT
0.4081 +0.01 (+2.03%)
After hours: 07:56PM EDT

IGC Pharma, Inc.

10224 Falls Road
Potomac, MD 20854
United States
301 983 0998
https://igcpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees61

Key executives

NameTitlePayExercisedYear born
Mr. Ram MukundaPresident, CEO & Director705kN/A1959
Ms. Claudia GrimaldiVP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director245kN/A1971
Mr. Rohit GoelSenior Director of Accounting & Principal Accounting OfficerN/AN/A1994
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Corporate governance

IGC Pharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.